PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Bioquímica Experimental e Computacional de Fármacos, Rio de Janeiro, RJ, Brasil.\', \'Universidade Federal do Rio de Janeiro, Instituto de Química, Laboratório de Síntese Orgânica e Prospecção Biológica, Rio de Janeiro, RJ, Brasil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0074-0276202000010020210.1590/0074-02760200254
?:hasPublicationType
?:journal
  • Memorias do Instituto Oswaldo Cruz
is ?:pmid of
?:pmid
?:pmid
  • 33027420
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.172
?:rankingScore_hIndex
  • 76
?:title
  • COVID-19: molecular targets, drug repurposing and new avenues for drug discovery.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33027420>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33027420>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all